Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Therefore, even individuals without childhood eczema may experience it later in life. Dr Grant has debunked the common ...

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...

The company paused testing of one candidate acquired in its April deal for Escient and scrapped another in a blow to its ...

Read on to learn more about canine allergies and dog allergy medications ... also known as atopic dermatitis, are estimated to affect 10-15 percent of dogs. Affected dogs often experience seasonal ...

British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...

There are lots of misconceptions around eczema, from poor hygiene to the skin condition disappearing on its own - there is a ...

The once-daily pill, icotrokinra, was tested in patients with moderate-to-severe plaque psoriasis, a skin condition that ...